diagnostic test for type1 and type 2 diabetes
diabetes diagnosis
ADA Standards of Care 2026 diagnosis diabetes type 1 type 2 diagnostic tests
| Test | Diagnostic result |
|---|---|
| HbA1c | ≥ 6.5% |
| Fasting plasma glucose (FPG) after at least 8 hours fasting | ≥ 126 mg/dL (≥ 7.0 mmol/L) |
| 75-g oral glucose tolerance test (2-hour plasma glucose) | ≥ 200 mg/dL (≥ 11.1 mmol/L) |
| Random plasma glucose with classic symptoms of hyperglycemia or hyperglycemic crisis | ≥ 200 mg/dL (≥ 11.1 mmol/L) |
| Suspected type | Helpful tests | Typical interpretation |
|---|---|---|
| Type 1 diabetes | Pancreatic islet autoantibodies: GAD65 first, then IA-2 and/or ZnT8; insulin autoantibodies may help before insulin treatment | Positive antibodies support autoimmune type 1 diabetes. |
| C-peptide with a simultaneous glucose level | Low or absent C-peptide indicates markedly reduced endogenous insulin production, supporting type 1 diabetes. | |
| Type 2 diabetes | HbA1c/FPG/OGTT for diagnosis; C-peptide and antibodies only if classification is uncertain | Autoantibodies are usually negative and C-peptide is usually preserved, especially early in disease. |